Updated Results of a Phase 2 Study of Biweekly Dose-Intense Paclitaxel Plus Gemcitabine (GEM/TAX) in Patients With Recurrent Locoregional or Metastatic Head-and-Neck Squamous Cell Carcinoma

Journal article

Open access

Peer reviewed

M. Salem, M. Kaufman, S. Shahrestani, M. Al-Hajeili, J. Jacobs, G. Yoo, H. Lin, D. Smith, L. Heilbrun and A. Sukari

International journal of radiation oncology, biology, physics, Vol.88(2), pp.506-506

02/2014

Files and links (1)

url

https://doi.org/10.1016/j.ijrobp.2013.11.137View

Published (Version of record) Open

1 Record Views

Title: Updated Results of a Phase 2 Study of Biweekly Dose-Intense Paclitaxel Plus Gemcitabine (GEM/TAX) in Patients With Recurrent Locoregional or Metastatic Head-and-Neck Squamous Cell Carcinoma
Creators - without role: M. Salem - The Barbara Ann Karmanos Cancer Institute
M. Kaufman - Wayne State University
S. Shahrestani - Wayne State University
M. Al-Hajeili - The Barbara Ann Karmanos Cancer Institute
J. Jacobs - Wayne State University
G. Yoo - The Barbara Ann Karmanos Cancer Institute
H. Lin - The Barbara Ann Karmanos Cancer Institute
D. Smith - The Barbara Ann Karmanos Cancer Institute
L. Heilbrun - The Barbara Ann Karmanos Cancer Institute
A. Sukari - The Barbara Ann Karmanos Cancer Institute
Publication Details: International journal of radiation oncology, biology, physics, Vol.88(2), pp.506-506
Identifiers: 9939144908331
Academic Unit: King Abdulaziz University
Language: English
Resource Type: Journal article